John Spinale - 22 Feb 2024 Form 4 Insider Report for Akili, Inc.

Role
Director
Signature
/s/ Jacqueline Studer, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Feb 2024
Net transactions value
$0
Form type
4
Filing time
23 Feb 2024, 17:43:26 UTC
Previous filing
23 Feb 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKLI Stock Option (Right to Buy) Award $0 +44,000 $0.000000 44,000 22 Feb 2024 Common Stock 44,000 $0.2200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable in three (3) equal annual installments on each of the first three anniversaries of the grant date, subject to the reporting person's continued service on each such vesting date.